<DOC>
	<DOCNO>NCT00861757</DOCNO>
	<brief_summary>This study randomize , double-blind , placebo tamsulosin-controlled , parallel design , multinational study evaluate efficacy safety Tadalafil once-a-day dose 12 week Asian men sign symptom benign prostatic hyperplasia ( BPH ) .</brief_summary>
	<brief_title>Multinational Study Evaluate Tadalafil Asian Men With Signs Symptoms Benign Prostatic Hyperplasia</brief_title>
	<detailed_description />
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<mesh_term>Signs Symptoms</mesh_term>
	<mesh_term>Tamsulosin</mesh_term>
	<mesh_term>Tadalafil</mesh_term>
	<criteria>Asian male , benign prostatic hyperplasia ( BPH ) least 6 month prior initiation IPSS score great equal 13 beginning treatment Agree use approve experimental pharmacologic BPH , erectile dysfunction ( ED ) overactive bladder ( OAB ) treatment time study . Have take Finasteride Dutasteride therapy , Antiandrogenic hormone BPH therapy , ED OAB therapy specify duration time prior begin treatment Prostate specific antigen ( PSA ) score beyond acceptable range define study initiation History urinary retention lower urinary tract ( bladder ) stone within 6 month initiation History urinary urethral obstruction due stricture , valve , sclerosis , tumor initiation Clinical evidence prostate cancer initiation Clinical evidence bladder urinary tract condition , may affect low urinary tract symptom initiation History cardiac condition , include Angina require certain treatment nitrate , unstable angina define study , positive cardiac stress test start study History significant central nervous system injury ( include stroke spinal cord injury within 6 month initiation ) Use nitrate , cancer chemotherapy , androgen , antiandrogens , estrogen , luteinizing hormonereleasing hormone ( LHRH ) agonists/antagonists , anabolic steroid initiation</criteria>
	<gender>Male</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
</DOC>